Wild-type (wt) p53 protein is rapidly degraded, has a short half-life and low intracellular levels. Stabilization of wt p53 protein following an appropriate stimulus (for example DNA damage) is a physiological regulation to increase function. In contrast, stabilization of p53 protein in the absence of a stimulus is always a hallmark of loss of function secondary to a mutation, or interaction with viral or cellular oncoproteins. It is generally accepted that stability of p53 protein depends on its intrinsic biochemical properties such as conformation or protein/protein interactions. However, I will discuss evidence that the stability of p53 is not a consequence of its intrinsic properties, but instead is determined by feedback control of its function. In the absence of an appropriate stimulus, a cell needs to keep p53 levels low, since increased levels can lead to apoptosis. To precisely regulate p53 levels, a cell must sense its level; and sensing its transactivating function, is the simplest way to sense p53. Following an appropriate stimulus (for example, DNA damage), the cell senses a state of`relative' p53 de®ciency and adapts by reducing p53 degradation. When the state of p53 de®ciency is a consequence of a mutation or interaction with viral oncoproteins, the cell does not sense p53, and again attempts to adapt by reducing p53 degradation. However, in the latter case, the increase in levels does not restore function, and the adaptation continues until degradation of p53 protein is maximally inhibited. In this case, no further inhibition of degradation is possible after DNA-damage or pharmacological inhibition of proteasomes. Thus lack of wt p53 function always results in increased p53 levels and nonregulation.
Introduction p53 stability and function p53 is the most commonly mutated gene found in human cancer Levine et al., 1991) . Mutant p53 protein has a prolonged half-life and accumulates in cells at high levels (Jenkins et al., 1985; Bartek et al., 1990; Iggo et al., 1990) . Indeed, detection of p53 by immunohistochemistry in tumors is considered an indication of a mutation (Hall et al., 1991) . Although the mechanisms of stabilization of mutant p53 are not clear, altered conformation, oligomerization, and interaction with other proteins like hsp70 have been proposed as potential explanations (Finlay et al., 1988; Sturzbecher et al., 1988; Kraiss et al., 1991) . However, stabilization is not solely a property of mutant p53 protein, since it can also occur with wild-type p53 following a variety of stimuli, and these can result in either a decrease or an increase in function (Table 1) . Thus, p53 elevation following transformation by DNA tumor viruses [SV40 large Tantigen (Oren et al., 1981; Sarnow et al., 1982; Deppert and Haug, 1986) , E1B and E1A oncoproteins (Braithwaite and Jenkins, 1989; Yew and Berk, 1992; Steegenga et al., 1996) ] results in a loss of p53 function. In contrast, stabilization following pharmacological stimuli, including DNA damage, hypoxia, depletion of ribonucleotide pools, and microtubule disruption, result in a higher level of a functional p53 (Maltzman and Czyzyk, 1984; Kastan et al., 1991 Kastan et al., , 1992 Fritsche et al., 1993; Graeber et al., 1994; Blagosklonny et al., 1995a; Chernova et al., 1995; Tishler et al., 1995; Wahl et al., 1996; Linke et al., 1996) . While the disposition of wt p53 is of interest in normal cellular physiology, the eect of acquired mutations has received intense scrutiny because of a possible etiologic role in the development of cancer. Previous studies have demonstrated that the majority of p53 mutations result in a mutant conformation (Cook and Milner, 1990; Gannon et al., 1990) . In addition, it has been shown that mt p53 can drive wt p53 into a mutant conformation leading to its inactivation (dominantnegative eect of mt p53) Milner and Medcalf, 1991; Chen et al., 1990; Kern et al., 1992; Srivastava et al., 1993) . Such mutants with dominantnegative eects are most commonly found in cancer (Brachmann et al., 1996) ; and the conformational eect on the wt allele depends on ratio of mt and wt p53 in vitro (Milner, 1995) . This can explain how mutations that lead to increased stability and inactivation of the wt allele have a selective advantage. While this explains how mt p53 stability can contribute to the development of cancer, it does not explain how this stability originated. Moreover, mt p53 can have a wild-type conformation (see Rolley et al., 1995) . In addition, u.v. stabilized wt p53 in wild-type conformation (Liu et al., 1994) . A dominant-negative eect also does not explain the stabilization of wt p53 that accompanies interaction with viral oncoproteins.
Indeed, there is evidence that the stability of mt p53 is not a property of p53 per se. For example, wt and mt p53 have been shown to accumulate to similar levels when translated in vitro or expressed in yeast (Blagosklonny et al., 1996a; Brachmann et al., 1996) , although the same mt p53 had a prolonged half-life when expressed in cells . In addition, cell type-speci®c regulation of wt p53 stability has been demonstrated (Delmolino et al., 1993) . These observations have led to the proposal that the cellular environment plays a critical role in determining p53 protein levels, and that mutations in p53 itself are not a sucient explanation for the elevated levels of p53 seen in human tumor cell lines (Vojtesek and Lane, 1993) . Instead, it has been suggested that dierences in p53 stability depend on the`cellular background' (Reihsaus et al., 1990) . In order to determine the nature of the cellular background we need to consider how p53 function is normally regulated.
WT p53 levels are regulated by alterations in the rate of degradation Modulation of the levels of any protein can be achieved by regulating production and/or degradation. In the case of p53 protein, the evidence indicates that its levels are almost exclusively regulated by the rate of degradation.
WT p53 is degraded through proteasomes (Ciechanover, 1994) and by calpain Zhang et al., 1997; Gonen et al., 1997) and inhibition of proteasomes leads to accumulation of wt p53 (Maki et al., 1996; Blagosklonny et al., 1996b; Dietrich et al., 1996) . Similarly, the levels of wt p53, can be increased by DNA-damaging agents (Maltzman and Czyzyk, 1984 ; Kastan et al., 1991 Kastan et al., , 1992 Fritsche et al., 1993) , and some other stimuli. These stimuli lead to increased p53 levels without an increase in mRNA levels; and inhibitors of transcription (high dose actinomycin-D) do not block but induce p53 accumulation (Kastan et al., 1991) . Increased translation following DNA-damage has been proposed (Kastan et al., 1991) , but the signi®cance of this remains unclear. A large body of evidence suggests that stabilization of p53 protein is the main mechanism to increase its levels. This stabilization occurs as a result of a decrease in degradation that increases the half-life of p53. The terms stabilization, increased half-life, and inhibition of degradation are synonyms.
Model: Loss of p53 function blocks its degradation by feedback control
Most current models envision structural alterations in p53 including acquired mutations leading to p53 stabilization and loss of function. Here I present a model that inverts this`cause-eect relationship' between stability and function. According to this model, loss of function leads to increased stability of mt or otherwise inactivated p53 (Figure 1 ).
Then how does loss of function stabilize p53?
As discussed, a cell requiring more p53 function can increase p53 levels by decreasing degradation (for example following DNA damage, Figure 2a ). I propose this mechanism of up-regulation precludes stabilization when function is lost (mutant or inactive p53). One can envision this occurring if the response of a cell when it`senses' insucient or absent p53 function is to block degradation. Under normal circumstances, this would result in constant levels of a functional p53. However, when p53 is nonfunctional, this adaptation results in higher levels of a disabled p53. In the latter situation, the decrease in degradation may be maximal as the cell attempts to compensate; and since physiologic regulation of p53 levels also involves inhibition of degradation, stimuli such as DNA damage, which normally up-regulate p53 are unable to further increase p53. This results in the peculiar situation of a high basal level which cannot be further increased by direct or indirect stimuli ( Figure  1b) . One can view this model as another example of a classic`feedback control mechanism'. Sensing p53 requires normal p53 trans-activating function, which (Table 1) can prevent this degradation at several levels. (b) P53 function is lost: p53 protein levels are increased. Physiological and pharmacological stimuli cannot up-regulate p53 further leads to induction of one or several proteins (`sensor proteins') that in turn may stimulate the p53 degradation pathway (Figure 2a) . Stabilization of p53 occurs when function is impaired and`sensor proteins' are not induced (Figure 2b) . In other words, when a cell does not sense p53 it does not degrade it. Proposed sensor proteins' must have the following characteristics: (1) they are induced by wt p53, (2) loss of expression results in elevation of p53 (including wildtype); and (3) induction results in decreased levels of p53 (including mutant). Recently it has been shown that mdm-2 which is transactivated by wt p53 targeted p53 for degradation (Haupt et al., 1997; . Therefore mdm-2 may be a sensor protein.
The main prediction of this model is stabilization of impaired p53. This can be illustrated by two mechanisms of p53 inactivation.
Inactivation by oncoproteins stabilizes wt p53
Both viral oncoproteins and some cellular proteins can stabilize p53. Three viral oncoproteins have been reported to inhibit p53 function and increase its levels: (1) Ad E1b, a 55-kD protein, forms a complex with p53, disrupting its trans-activational activity but also leading to its stabilization (Lane and Crawford, 1979; Linzer and Levine, 1979; Oren et al., 1981; Sarnow et al., 1982; Braithwaite and Jenkins, 1989; Yew and Berk, 1992) . (2) SV40 large T antigen binds to p53 eliminating wt p53 speci®c functions and stabilizes p53 (Braithwaite and Jenkins, 1989; Farmer et al., 1992) . Although large T antigen can form complexes with p53, free p53 is also stable (Deppert and Haug, 1986; Deppert and Steinmayer, 1989) . (3) Finally, E1A also blocks the trans-activation function of wt p53 (Steegenga et al., 1996; Somasundaram and El-Deiry, 1997 ). Similar observations have been made with some cellular proteins. For example, the Wilms' tumor-suppressor gene product, WT1, can modulate p53's transactivational properties and lead to its stabilization (Maheswaran et al., 1995) .
Although these proteins are very dierent, the common outcome is the loss of p53 function, not complex formation (Farmer et al., 1992; Deppert et al., 1987) . Complex formation with T antigen (and HSP70) does not directly stabilize p53 (Halevy et al., 1989) . Moreover, E1A does not form a complex with p53 (Debbas and White, 1993) . Even stabilization of wt p53 in SV40 transformed cells is independent of complex formation (Deppert and Haug, 1986; Deppert and Steinmayer, 1989) . It has been speculated that small t and large T antigens cooperate in inducing or repressing a cellular factor that is involved in controlling p53 turnover. Considering that stabilization of p53 is a viral function, the correlation between metabolic stabilization of p53 and enhanced transformation eciency (Tiemann et al., 1995) have simple explanation: p53 stabilization occurs only when its function is lost.
Mutations also inactivate and stabilize p53
As proposed above, the increased stability of mutant p53 proteins would be a consequence of the adaptations occurring following loss of function. If function is abolished, stabilization would be maximal, precluding further stabilization after pharmacological stimuli. While a mutant conformation abolishes the transactivation function of p53 (Milner, 1995) , stabilization of p53 does not require a mutant conformation sincè contact' mutants are also stable despite having a wildtype conformation. The common feature is impairment in transactivation function. According to the model, only mutations that lead to impaired function produce a stable p53. The observation that proteasome inhibitors cannot induce mt p53, would be an expected consequence of this adaptation (Blagosklonny et al., 1996b) . Indeed in contrast to the accumulation of wt p53 that follows treatment with proteasome inhibitors, mt p53 levels decrease (Blagosklonny et al., 1996b) . This can be explained if one recognizes that proteasome blocker also inhibits degradation of sensor protein(s). The resultant increase in the levels of sensor protein(s) would be interpreted by the cell as a partial restoration of p53 transactivation, and would lead to degradation of some fraction of p53 by the remaining proteasome activity. Finally, although the hypothesis envisions a`feedback regulation' as the principal mechanism responsible for accumulation of p53, it does not preclude a role for an altered conformation in the stabilization of mt p53, since altered conformation abolishes its function. For example, geldanamycin favors the wild-type conformation of p53, and results in decreased mt p53 stability (Blagosklonny et al., 1995b; 1996a) .
Interactions between wt and mut p53
Mutant p53 can exert dominant-negative eects which may foster tumorigeneses Milner and Medcalf, 1991) . Although the majority of mt p53 can block wt p53 at equivalent levels in vitro (Brachmann et al., 1996) , the outcome depends on the ratio of two proteins (Milner, 1995) . Speci®cally, if increased stability were a direct result of mutations, mt p53s would be intrinsically more stable and could exert complete dominance over wt p53, since this eect depends principally on the wt:mut ratio. However, most human tumors expressing mutant p53 have lost the wild-type allele . One must wonder why this would be necessary? And why introduction of wt p53 in vivo often exerts a dominant eect.
These contradictions can be resolved by the proposed model. According to this view, degradation depends on what a cell`senses'. If wt p53 is present, a cell senses some functional p53; but because it cannot discriminate mt and wt p53, both are degraded at comparable rates (Figure 3) . So that the model predicts that when both wt and mt p53 are expressed, mt p53 Loss of function and p53 protein stabilization MV Blagosklonny cannot take advantage of the stability that results from the decrease in function. In agreement with this, it has been shown that cells which are heterozygous contain approximately equal amounts of wt p53 and mt p53 (Srivastava et al., 1992; Srivastava et al., 1993) and that the levels of wt p53 are higher in the presence of cotransfected mt p53 (Ullrich et al., 1992) . In the latter, the reduction in p53 activity that occurs when one allele exerts dominant-negative eect, leads to a decrease in`sensing', with a compensatory reduction in degradation of both alleles, since the degradation process cannot discriminate between wt and mt p53. The logical consequence is that a cell which acquires a mt p53 allele will have its tumorigenic potential enhanced by deletion of the wt allele (Figure 3) .
Finally additional evidence supports the thesis that wt p53 function determines the stability of any p53; wt or mt. For example, a 175His mutant lacking the Cterminus (and therefore unable to block wt p53) has been shown to be signi®cantly less stable than the 175His with a normal C-terminus . Because the mutant lacking the C-terminus is unable to block wt p53, the cell would continue to`sense' normal p53 activity and degradation of both p53 would proceed at a normal rate. Similarly, p53[1 ± 326], a wt p53 which lacks the C-terminus (disabled wt p53) has been shown to accumulate to higher levels than wt p53 when expressed in p53 null cells (Zhang et al., 1994) . Furthermore wt p53 has been shown to suppress the expression of p53[1 ± 326]; but p53 [1 ± 326] does not aect the expression of wt p53 (Zhang et al., 1994) . Thus the stability of overexpressed truncated wt p53 depends on the extent of p53 function. Moreover, p53's lysine mutants were expressed at similar levels as wt p53 in vivo, except (I132) p53 mutant that accumulated at very high levels. All mutants retained the transactivation ability except the last one (I132) (Crook et al., 1996) .
These observations support the thesis that stability of any p53, wt or mut, depends principally on the level of p53 activity`sensed' by the cell.
Conclusions
A model is presented that envisions p53 activity as the principal determinant of p53 stability. Feedback control determines p53 levels by regulating its degradation and therefore functional inactivation of p53 leads to accumulation of p53 protein. Accumulation of p53 in the absence of pharmacological/ physiological stimuli is always a marker of nonfunctional p53. In fact, any accumulation of p53, regardless of the mechanism, can enhance the malignant phenotype (Elledge et al., 1994) .
The most important evidence lacking in support of the model was the identity of the sensor protein(s). While the present manuscript was under review it was shown that mdm-2 protein which was transactivated by wt p53 targeted p53 for degradation (Haupt et al., 1997; . Potentially it may be proved that mdm-2 is a sensor protein. The identification of the sensor proteins, will provide ultimate proof of the model and more importantly, identify potential targets or pathways to manipulate p53 levels. Such interventions may ultimately improve the therapy of cancer.
